Table 2.
No | SNP name | Gene name | Disease | MAF | OR |
OR |
OR |
Reference |
---|---|---|---|---|---|---|---|---|
T2DM | Obesity | Hypertension | ||||||
1 | rs2383208 | CDKN2A/B | T2D | 0.40 | 4.1 | 4.0 | 2.6 | Saxena, Voight et al. (2007) |
2 | rs13266634 | CDKAL1 | T2D | 0.45 | 1.2 | 2.1 | 1.8 | Chimienti, Devergnas et al. (2004) |
3 | rs4712523 | CDKAL1 | T2D | 0.38 | 2.1 | 0.8 | 2.0 | Steinthorsdottir, Thorleifsson et al. (2007) |
4 | rs1111875 | HHEX | T2D | 0.35 | 2.9 | 1.1 | 1.2 | van Vliet-Ostaptchouk, Onland-Moret et al. (2008) |
5 | rs4402960 | IGF2BP2 | T2D | 0.21 | 1.0 | 1.4 | 1.9 | Nielson, Czech et al. (1999) |
6 | rs5219 | KCNJ11 | T2D | 0.38 | 1.9 | 0.8 | 0.8 | Vaxillaire et al. (2008) |
7 | rs1801282 | PPARG | T2D | 0.07 | 1.0 | 5.1 | 0.5 | Altshuler, Hirschhorn et al. (2000) |
8 | rs7903146 | TCF7L2 | T2D | 0.04 | 2.7 | 2.4 | 3.1 | Grant, Thorleifsson et al. (2006) |
9 | rs10012946 | WFS1 | T2D | 0.08 | 3.0 | 2.8 | 3.6 | Sandhu, Weedon et al. (2007) |
10 | rs3751812 | FTO | Obesity | 0.15 | 1.1 | 1.9 | 4.4 | Frayling, Timpson et al. (2007); Hennig, Fulford et al. (2009) |
11 | rs662799 | APOA5 | Obesity | 0.32 | 2.0 | 1.9 | 2.6 | Corella, Lai et al. (2007) |
12 | rs766605 | INSIG2 | Obesity | 0.03 | 1.8 | 1.7 | 2.4 | Dina, Meyre et al. (2007) |
13 | rs10871777 | MC4R | Obesity | 0.12 | 0.6 | 2.4 | 1.1 | Loos, Lindgren et al. (2008) |
14 | rs12970134 | MC4R | Obesity | 0.14 | 0.5 | 6.1 | 1.1 | Chambers, Elliott et al. (2008) |
15 | rs3772622 | ATGR1 | NAFLD | 0.46 | 0.3 | 1.4 | 0.8 | Yoneda, Hotta et al. (2009) |
16 | rs1014290 | SLC2A9 | Hypertension | 0.37 | 3.1 | 3.1 | 3.3 | Vitart, Rudan et al. (2008) |
17 | rs6449213 | SLC2A9 | Hypertension | 0.02 | 1.4 | 5.2 | 7.3 | Vitart, Rudan et al. (2008) |
18 | rs737267 | SLC2A9 | Hypertension | 0.01 | 0.0 | 5.1 | 7.0 | Vitart, Rudan et al. (2008) |
19 | rs3754777 | STK39 | Hypertension | 0.24 | 1.7 | 1.7 | 0.7 | Wang, O'Connell et al. (2009) |
20 | rs2383207 | CDKN2BAS | Heart attack | 0.40 | 1.0 | 0.9 | 1.7 | Scheffold et al. (2011) |
MAF is minor allele frequency.
OR is odds ratio.
NAFLD is non-alcoholic fatty liver disease.